PLYMOUTH MEETING, Pa. & SALT LAKE CITY--(BUSINESS WIRE)--May 17, 2013--IMS Health and Remedy Informatics today announced a strategic alliance to deliver technology-enabled Real-World Evidence (RWE) solutions for life sciences organizations worldwide. The alliance brings together IMS Health’s market-leading RWE capabilities and anonymous patient-level information assets with Remedy Informatics’ innovative Mosaic™ technology solution — providing the industry’s most complete understanding of healthcare effectiveness, safety and value. The combination extends IMS Health’s scalable RWE platform, which leverages proprietary technology to connect and analyze de-identified patient information from sources that include disease registries, electronic health records and claims databases. The new suite of solutions will be offered as IMS Evidence 360º.
Applying flexible data integration, visualization and reporting applications, IMS Evidence 360º will enable pharmaceutical and medical device manufacturers, payers and providers to link and analyze complex healthcare data sets. It will be a key component of IMS Health’s expanded RWE platform supporting a broad range of applications, from epidemiological studies and comparative effectiveness and safety research, to commercial analytics.
“Today, life sciences organizations recognize the increasing role of real-world evidence in facilitating a deeper understanding across the patient journey — and the power of technology in advancing the healthcare value dialogue,” said Andrew Kress, senior vice president, IMS Healthcare Value Solutions. “With this alliance, we are bringing together proven expertise, scalable applications and the industry’s most robust data management and structured analytics to enable innovative, integrated patient-level insights.” IMS Evidence 360º will feature a number of enhanced capabilities, including: Seamless data integration to create novel disease-centric information assets across clinical, observational and claims data sets Advanced data capture and registry building Sophisticated, therapy area-specific analyses applying customized disease definitions Flexible user interface for dynamic, efficient research functionality, including queries to identify patterns without complex programming Intuitive visual interrogation, reporting and dashboarding tools to facilitate analytical workflow and cohort building “We are pleased to enter this agreement with IMS Health,” said Gary Kennedy, founder and CEO, Remedy Informatics. “A key challenge for life sciences clients is how to best connect and integrate data for a complete picture of the patient experience. Only IMS Health has the breadth of anonymous patient-level data assets — and depth of HEOR expertise. Remedy Informatics’ technology can combine that kind of insight with the harmonization and rigor only our Mosaic Platform can offer. Together, we will deliver next-generation solutions that support healthcare stakeholders in examining the real-world costs, risks and benefits of specific treatments.” About Remedy Informatics, Inc. Remedy Informatics, Inc. is the leading provider of patient registries, medical research software and research informatics products that accelerate translational medicine discoveries from bench to bedside. The company, whose mission is to tangibly, measurably and permanently improve the effectiveness of life sciences research and healthcare delivery in the United States and around the world, offers a wide range of highly configurable biomedical informatics products built on the powerful Mosaic™ Platform.
Remedy Informatics’ technology solutions serve a wide range of leading clinical and life sciences research institutions, including Massachusetts General Hospital, Baylor Health Care System, Genentech, Cancer Treatment Centers of America, Princess Margaret Cancer Centre, Huntsman Cancer Institute at the University of Utah, Indiana University, the European Group for Blood and Marrow Transplantation (EBMT) and many more. For additional information visit: www.remedyinformatics.com.
About IMS Health
IMS Health is a leading worldwide provider of information, technology and services dedicated to making healthcare perform better. With a global technology infrastructure and unique combination of real-world evidence, advanced analytics and proprietary software platforms, IMS Health connects knowledge across all aspects of healthcare to help clients improve patient outcomes and operate more efficiently. The company’s expert resources draw on data from nearly 100,000 suppliers, and on insights from more than 40 billion healthcare transactions processed annually, to serve more than 5,000 healthcare clients globally. Customers include pharmaceutical, medical device and consumer health manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at www.imshealth.com.
As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes.